134 related articles for article (PubMed ID: 37006066)
1. An experience with simultaneous integrated boost-volumetric-modulated arc therapy in the definitive treatment of head and neck cancer: An Indian data.
Shivananjappa R; Mandal SK; Vishwanathan B; Geeta SN
J Cancer Res Ther; 2023; 19(2):283-288. PubMed ID: 37006066
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized comparison of simultaneous integrated boost with sequential boost intensity-modulated radiotherapy in locally advanced head and neck cancer.
Mani N; Aggarwal SK; Kumar I; Mandal A; Jaiswal G; Ranjan R; Jaiswal AK; Gupta N; Singh A; Mourya A; Aggarwal LM; Choudhary S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S455-S459. PubMed ID: 36511003
[TBL] [Abstract][Full Text] [Related]
4. Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?
Buciuman N; Marcu LG
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5311-5321. PubMed ID: 35598230
[TBL] [Abstract][Full Text] [Related]
5. A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer.
Mandal A; Choudhary S; Mani N; Aggarwal SK
J Cancer Res Ther; 2020; 16(3):508-512. PubMed ID: 32719258
[TBL] [Abstract][Full Text] [Related]
6. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
8. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.
Moncharmont C; Vallard A; Mengue Ndong S; Guy JB; Saget C; Méry B; Langrand-Escure J; de Laroche G; Goyet D; Prades JM; Fournel P; Magné N
Acta Otolaryngol; 2016; 136(2):181-8. PubMed ID: 26503806
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients.
Dragan T; Beauvois S; Moreau M; Paesmans M; Vandekerkhove C; Cordier L; Van Gestel D
Oral Oncol; 2019 Nov; 98():132-140. PubMed ID: 31586895
[TBL] [Abstract][Full Text] [Related]
10. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
[TBL] [Abstract][Full Text] [Related]
11. Comparative treatment planning study on sequential vs. simultaneous integrated boost in head and neck cancer patients: Differences in dose distributions and potential implications for clinical practice.
Stromberger C; Ghadjar P; Marnitz S; Thieme AH; Jahn U; Raguse JD; Karaj-Rossbacher E; Böttcher A; Jamil B; Budach V
Strahlenther Onkol; 2016 Jan; 192(1):17-24. PubMed ID: 26462675
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.
Macchia G; Cilla S; Morganti AG; Deodato F; Legge F; Piermattei A; Chiantera V; Scambia G; Valentini V; Ferrandina G
Acta Oncol; 2014 Feb; 53(2):251-8. PubMed ID: 24050516
[TBL] [Abstract][Full Text] [Related]
14. Skin dose differences between intensity-modulated radiation therapy and volumetric-modulated arc therapy and between boost and integrated treatment regimens for treating head and neck and other cancer sites in patients.
Penoncello GP; Ding GX
Med Dosim; 2016; 41(1):80-6. PubMed ID: 26764180
[TBL] [Abstract][Full Text] [Related]
15. Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
Franzese C; Fogliata A; Clerici E; Franceschini D; Villa E; D'Agostino G; Navarria P; Mancosu P; Tomatis S; Cozzi L; Scorsetti M
Radiat Oncol; 2015 Nov; 10():224. PubMed ID: 26545871
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
[TBL] [Abstract][Full Text] [Related]
17. Change in the Quality of Life in Oropharyngeal, Laryngeal and Hypopharyngeal Cancer Patients treated with Volumetric Modulated Arc-Based Concomitant Boost Radiotherapy.
Kannan P; Mukherji A; Saravanan K; Reddy KS; Vivekanandam S; Shamsudheen C; Santhosh V
Gulf J Oncolog; 2016 May; 1(21):36-45. PubMed ID: 27250886
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sequential versus simultaneous integrated boost of volumetric modulated arc therapy in treatment of oropharyngeal carcinoma.
Kachhwaha A; Tiwari R; Gayen S; Manna S; Solanki A; Devnani B; Pareek P
Cancer Treat Res Commun; 2023; 36():100721. PubMed ID: 37301126
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost (IMRT-SIB) in head and neck squamous cell carcinoma in patients not suitable for chemo-radiotherapy.
Rastogi M; Sapru S; Gupta P; Gandhi AK; Mishra SP; Srivastava AK; Khurana R; Hadi R; Sahni K; S F
Oral Oncol; 2017 Apr; 67():10-16. PubMed ID: 28351562
[TBL] [Abstract][Full Text] [Related]
20. Reducing Salivary Toxicity with Adaptive Radiotherapy (ReSTART): A Randomized Controlled Trial Comparing Conventional IMRT to Adaptive IMRT in Head and Neck Squamous Cell Carcinomas.
Ghosh Laskar S; Sinha S; Kumar A; Samanta A; Mohanty S; Kale S; Khan F; Lewis Salins S; Murthy V
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):353-361. PubMed ID: 38575432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]